AAA
Affinity Asset Advisors’s Astria Therapeutics ATXS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
+300,000
| New | +$1.61M | 0.22% | 57 |
|
|
2024
Q4 | – | Sell |
-725,106
| Closed | -$7.98M | – | 78 |
|
|
2024
Q3 | $7.98M | Sell |
725,106
-250,500
| -26% | -$2.76M | 1.09% | 26 |
|
|
2024
Q2 | $8.88M | Buy |
975,606
+130,000
| +15% | +$1.18M | 1.02% | 26 |
|
|
2024
Q1 | $11.9M | Sell |
845,606
-620,859
| -42% | -$8.74M | 1.47% | 18 |
|
|
2023
Q4 | $11.3M | Buy |
1,466,465
+466,165
| +47% | +$3.58M | 2.06% | 16 |
|
|
2023
Q3 | $7.46M | Buy |
1,000,300
+349,425
| +54% | +$2.61M | 2.1% | 13 |
|
|
2023
Q2 | $5.42M | Buy |
650,875
+121,506
| +23% | +$1.01M | 1.89% | 15 |
|
|
2023
Q1 | $7.04M | Buy |
529,369
+56,887
| +12% | +$757K | 2.32% | 14 |
|
|
2022
Q4 | $7.04M | Buy |
472,482
+72,439
| +18% | +$1.08M | 2.76% | 12 |
|
|
2022
Q3 | $3.62M | Buy |
+400,043
| New | +$3.62M | 1.01% | 24 |
|